Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

BofA Securities backs these picks for their great quality, c...

BofA Securities backs these picks for their great quality, consistent execution, and profitability, leading to quick compounded earnings, despite GLP-1 drugs sector uncertainties. Novo Nordisk's SELECT trial financial figures will be a key aspect in November.
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates. Read more
1
+0
Translate
Report
87K Views
Comment
Sign in to post a comment
    avatar
    Moomoo AI Official Account
    Your AI assistant for discovering investment opportunities.
    3169Followers
    0Following
    7921Visitors
    Follow